Medirom Healthcare Technologies (MRM) Stock News

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that its subsidiary, MEDIROM MOTHER Labs, has begun providing its REMONY remote health monitoring system to the Japan Ground Self-Defense Force (JGSDF). The system features the innovative MOTHER Bracelet®, a recharge-free smart tracker that uses thermoelectric generation technology.

The JGSDF's 8th Division adopted REMONY to address critical health monitoring challenges during extended missions. The system enables continuous health tracking without battery recharging, allowing commanding officers and medical staff to monitor personnel's real-time health conditions and prevent issues like heatstroke in extreme environments.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announced that its subsidiary MOTHER Labs' "REMONY for Driver" system has been certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT) as a fatigue-driving prevention device.

The REMONY system utilizes the MOTHER Bracelet for 24/7 driver health monitoring and includes a medical-supervised sleep assessment function. The certification makes the system eligible for a 50% subsidy on equipment acquisition costs, with a cap of 800,000 yen per business operator, from MLIT's approximately 1.3 billion yen subsidy program.

The system features charge-free operation, continuous health data collection, and trend analysis capabilities for preventing health-related accidents in the transportation industry.

MEDIROM Healthcare Technologies (NASDAQ:MRM) has announced its strategic entry into cryptocurrency and blockchain technology through participation in the "World" protocol, a proof-of-human authentication system. The company plans to install "Orb" authentication devices across approximately 100 Re.Ra.Ku relaxation salons, potentially reaching up to 500,000 individuals.

The initiative includes offering customers who verify their World ID approximately 8,000 Japanese yen worth of Worldcoin tokens (WLD). MEDIROM will accept WLD for Re.Ra.Ku Tickets and plans to convert up to 50% of acquired WLD into Ethereum (ETH) as part of its financial strategy. The company operates over 300 relaxation salons across Japan under various brands including Re.Ra.Ku, Spa Re.Ra.Ku, Re.Ra.Ku PRO, Bell Epoc, and Ruam Ruam.

MEDIROM Healthcare Technologies (NASDAQ:MRM) has announced a strategic partnership with Hakuhodo Inc. to join the World Network, a proof of human protocol co-founded by OpenAI creator Sam Altman. The company plans to install "Orb" verification devices in 100 Re.Ra.Ku relaxation salons by December 2025.

The initiative aims to issue 500,000 new World IDs annually, supporting the World protocol's mission to distinguish between humans and AI in the digital age. The World ID system, developed by Tools for Humanity (TFH), uses advanced camera technology to verify human authenticity while maintaining privacy. MEDIROM, which operates over 300 relaxation salons nationwide, will integrate this technology across its Re.Ra.Ku locations as part of the global deployment strategy.

MEDIROM Healthcare Technologies (NASDAQ: MRM) has successfully regained compliance with Nasdaq's minimum bid price requirement. The company, which received a non-compliance notice on February 27, 2025, was required to maintain a minimum closing bid price of $1.00 per share for at least 10 consecutive business days. Nasdaq confirmed that from May 20 to June 3, 2025, MRM's American Depositary Shares consistently met this requirement. The company had been given until August 26, 2025, to resolve the compliance issue, and has now successfully done so ahead of the deadline. With this achievement, Nasdaq has officially closed the matter, confirming MRM's continued listing status.

MEDIROM Healthcare Technologies (NASDAQ: MRM) announces significant milestones for its healthcare app 'Lav', with over 100 contracted companies and 10,000 supported individuals for specific health guidance services. The app, launched in 2019, has facilitated a total weight loss of 15,421 kg among users. Lav serves approximately 1 in 14 health insurance associations in Japan, offering personalized health coaching through chat features, activity tracking, and lifestyle management tools. The app supports Japan's Specific Health Guidance Program, targeting medical insurance subscribers aged 40-74 to prevent lifestyle-related diseases. Users can track weight, steps, sleep, and meals while receiving professional coaching support. The service has received positive evaluations and continues to expand its presence in Japan's healthcare technology sector.

MEDIROM Healthcare Technologies (MRM) reported strong financial results for 2024, with total revenue increasing 22% to $52.7M, up from $43.4M in 2023. Net income improved 20% to $878,000 ($0.17 per share) compared to $731,000 ($0.15 per share) in 2023. The growth was primarily driven by a 23% increase in the Relaxation Salon Segment revenue to $47.3M. The company's cost management improved, with cost of revenues decreasing to 72.9% from 77.0% and SG&A expenses dropping to 27.0% from 28.7%. Cash position strengthened to $2.1M, though total debt increased to $11.9M. In early 2025, MEDIROM completed a $5M ADS offering and secured a $2.4M bank loan. The company aims to expand its Digital Preventative Healthcare business and increase Lav® users through strategic initiatives.

MEDIROM Healthcare Technologies (Nasdaq: MRM) has scheduled a webcast for May 21, 2025, at 8:30 AM ET to discuss its financial results for fiscal year 2024. The company will release its financial results after market close on May 20, 2025. MEDIROM, a Japanese holistic healthcare company, operates 307 relaxation salons under the Re.Ra.Ku® brand and offers various healthcare services. The company has expanded into health tech with its on-demand training app "Lav®", developed the "MOTHER Bracelet®" smart tracker, and launched REMONY, a remote monitoring system for corporate clients. The webcast will be accessible via dial-in numbers for North America, International, and Japan participants, with a replay available until June 4, 2025.

MEDIROM Healthcare Technologies (Nasdaq CM: MRM) has secured a new unsecured short-term bank loan of JPY350 million (approximately $2.4 million) with a 1.875% annual interest rate. JPY200 million of the loan funds will be used to repay the indebtedness of MEDIROM Mother Labs Inc., a subsidiary and loan guarantor.

The remaining funds will support general working capital, including the development of Mother Bracelet. CEO Koji Eguchi stated that this financing strengthens their financial position and provides additional support for the Mother Bracelet development.